MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition.
Richard Riedel,Jana Fassunke,Andreas H. Scheel,Matthias Scheffler,Carina Heydt,Lucia Nogova,Sebastian Michels,Rieke N. Fischer,Anna Eisert,Heather Scharpenseel,Felix John,Lea Ruge,Diana Schaufler,Janna Siemanowski,Michaela A. Ihle,Svenja Wagener-Ryczek,Roberto Pappesch,Jan Rehker,Anne Bunck,Carsten Kobe,Felix Keil,Sabine Merkelbach-Bruse,Reinhard Buettner,Juergen Wolf Journal of Thoracic Oncology(2023)
关键词
Non-small cell lung cancer,MET fusion,Tyrosine kinase inhibitor resistance,MET inhibition
AI 理解论文
溯源树
样例
